AAP leader Atishi on Wednesday said Delhi received 2.67 lakh more doses of Covishield vaccine on May 11, but it has completely run out of Covaxin.

She said some Covaxin centres for the 18-44 age group have been temporarily shut from Wednesday.

"Around 16,000 Covaxin doses, which were available in the morning, were administered at 44 centres. These centres will also be shut after Wednesday evening," the AAP MLA said.

Atishi hoped that the central government would intervene and make Covaxin doses available for the 18-44 age category.

"Soon it will be time to give the second dose of Covaxin to beneficiaries in this category," she added.

The AAP leader said the national capital received 2.67 lakh more doses of Covishield on Tuesday evening.

There are 4.18 lakh Covishield doses left for people in the 18-44 age group. These can last up to nine days, she added.

"However, there will be no Covaxin doses left for the 18-44 age group after Wednesday evening and all such centres will be temporarily shut," she said.

Delhi currently has four days of Covaxin and three days of Covishield stock for those above 45, and healthcare and frontline workers.

The AAP leader said 1.28 lakh doses were administered in the city on Tuesday.

A total of 41.64 lakh doses have been administered to beneficiaries across all categories in Delhi since the inoculation drive started on January 16, according to the bulletin.

Delhi has so far received 8.17 lakh doses of coronavirus vaccines for the 18-44 category, and over 43 lakh doses for 45-plus, and healthcare and frontline workers.

Healthcare workers, frontline staff and those aged above 45 are being given jabs at 470 centres, whereas beneficiaries in the 18-44 age group are being inoculated at 394 centres.

Manish Sisodia slams Centre

Earlier in the day, Deputy Chief Minister Manish Sisodia said Bharat Biotech has informed the Delhi government that it cannot provide "additional" Covaxin doses to the national capital.

The stock of Covaxin in Delhi has finished and as a result around 100 vaccination centres set up in 17 schools have been closed, he said.

"The Covaxin manufacturer has in a letter said that it can not provide Delhi government vaccines due to unavailability, under the instruction of concerned government officials. It means that the central government is controlling the supply of the vaccine," Sisodia said.

The deputy chief minister said the Centre should stop the export of vaccines and share the vaccine formulae of the two manufacturers in the country with other companies for mass-scale production.

He also requested the Union government to approve vaccines available in the international market for use in India, and direct states to vaccinate everyone within three months.

In a tweet, Sisodia shared the letter sent to the Delhi government by Bharat Biotech, revealing that it cannot supply vaccines.

Hitting out at the Centre’s vaccine management, Sisodia wrote in the tweet, “Vaccine mismanagement by Centre-- Covaxin refuses to supply vaccine citing directives of Gov. & limited availability.

Once again I would say exporting 6.6cr doses was the biggest mistake. We are forced to shut down 100 covaxin-vaccination sites in 17 schools due to no supply.”

Bharat Biotech retorts

It is quite disheartening to listen to some states complaining about Bharat Biotech's intentions regarding the supply of COVID vaccine Covaxin, a top company official retorted.

In a tweet, Bharat Biotech Joint Managing Director Suchitra Ella said the company has already dispatched Covaxin lots to 18 states on May 10.

"18 states have been covered though in smaller shipments. Quite disheartening to the teams to hear some states complaining about our intentions. 50 of our employees are off work due to covid, yet we continue to work under pandemic lockdowns 24x7 for U," she said in a tweet.

The Hyderabad-based firm is supplying Covaxin to 18 states, including Andhra Pradesh, Haryana, Odisha, Assam, Jammu & Kashmir, Tamil Nadu, Bihar, Jharkhand and Delhi. Other states are Chhattisgarh, Karnataka, Telangana, Tripura, Madhya Pradesh, Uttar Pradesh, Gujarat, Maharashtra and West Bengal.